Background: Paracetamol exerts toxic effects on liver cells through its metabolism into N-acetyl-p-benzoquinone imine (NAPQI), which is detoxified by conjugation with cellular glutathione (GSH). Once GSH is depleted, NAPQI stimulates a range of oxidative reactions that result in cell necrosis. The aim of the present investigation is to find a new strategy that would selectively protect normal hepatic tissues and sensitize liver cancer cells to the toxic effects of paracetamol or its metabolite. This may lead to the development of a targeted therapy for liver cancer. Methods: The antiproliferative effects of paracetamol and buthionine sulfoximine BSO (a glutathione depleting agent) alone and in combination on the liver cancer cells HepG2 and normal rat hepatocytes were investigated by sulphorhodamine-B assay. Effects on cell cycle regulation and induction of apoptosis were tested by flow cytometry. The level of prostaglandin expression was measured by ELISA. Results: The present study showed that both agents alone or in combination have anti-proliferative effects on both cell types. Surprisingly, BSO showed a cytoprotective effects on normal hepatocytes treated with high concentrations (1.75 and 2 mM) of paracetamol. This was confirmed by cell cycle analysis that recorded decreased fraction of sub-G1 cells indicating reduction of apoptosis in normal hepatocytes. Analysis of prostaglandin E2 revealed differential effects of paracetamol on normal and liver cancer cells. A significant increase in PGE2 level over the control was observed in normal hepatocytes whereas a significant decrease was seen in HepG2 cells after treatment with paracetamol. Conclusion: These results indicate that combination of paracetamol/BSO has 
Introduction
Being the current leading cause of death worldwide, cancer is considered as one of the major health problems. Primary cancers of the liver represent the fifth most common malignancy worldwide and the second most common cause of death from cancer [1] . Traditional treatments for liver cancer are not entirely effective and their applications are limited. The goal of this study is to find strategies that would produce preferential protection of normal tissues or preferential sensitization of tumor cells.
In addition to its ability to treat pain and fever, Paracetamol was found to induce apoptosis and necrosis in various types of cultured liver carcinoma cells specially HepG2 cell line [2] . The key event of paracetamol cytotoxicity is its transformation into the reactive metabolite N-acetyl-p-benzoquinone imine (NAPQI) by cytochrome P450 family [3] [4] [5] [6] which can induce apoptosis or necrosis on different cell models [7] [8]. It's worth mentioning that HepG2 cells show high expression of mRNA and protein levels of cytochrome P450 2E1; the one responsible for bioactivation of NAPQI. In normal cases NAPQI is primarily detoxified by conjugation with intracellular glutathione (GSH). Many human tumor cells cultured in vitro were shown to contain extremely high levels of GSH [9] [10] which are particularly relevant in regulating mutagenic mechanisms. However, after cellular GSH depletion it is thought that NAPQI causes cytotoxicity by binding to cellular macromolecules, although the exact mechanism of cellular toxicity remains a subject of controversy [11] [12] . High levels of PGs have been reported for many types of cancer and it has been shown that GSH is needed for PGE2 production [13] . In vivo, paracetamol inhibits cyclooxygenase enzymes (COX) peripherally and centrally suppressing prostaglandins production. Buthionine sulfoximine (BSO) is a glutathione depleting agent that inhibits the enzyme gamma-glutamylcysteine synthetase which is required in the early steps of glutathione synthesis. It is being investigated as an adjunct with chemotherapy in the treatment of cancer and parasitic diseases [14] . The aim of the present study is to test the effect of buthionine sulfoximine and prostaglandin E level on the cytotoxic effects of paracetamol on cancer and normal liver cells. The ultimate goal is to find a novel more effective therapy for liver cancer.
Material and Methods

Cell Lines and Culture Conditions
Human liver carcinoma cell line (HepG2) and primary normal rat hepatocytes were used in this study. HepG2 cell line was purchased from American Type Culture collec-tion and was maintained in Dulbeco's Modified Eagle's Medium with phenol red (DMEM, Lonza, Belgium) supplemented with 10% fetal bovine serum (Cambrex, Belgium), penicillin/streptomycin (Lonza, Belgium). The Primary liver cells were isolated from male rat liver by two-step collagenase perfusion method according to Seglen [15] and were cultured in collagen-coated 96-well plates and 25 cm 2 
Chemosensitivity Assay
Cytotoxicity of paracetamol alone (Bristol-Myers Squibb Pharmaceuticals Ltd, Anagni, Italy) or in combination with DL-Buthionine-(S, R)-Sulfoximine (Sigma, USA) was determined using sulpho Rhodamine-B (SRB) method as previously described [16] . 
Cell Cycle Distribution Analysis
Cell cycle and apoptosis were analyzed by flowcytometry as previously described [17] . -cell culture flasks and treated after 24 h with either paracetamol alone or in combination with BSO then flasks were incubated at 37˚C. After 48 h, cell culture supernatants were collected and centrifuged. This cell extract was used to measure PGE2 quantitatively by mixing in a 96-well plate with the reagents supplied with the kit. The PGE 2 standard dilution series was made from the highest standard stock (supplied with the kit). The color development is stopped, and the absorbance is read at 450 nm using a spectrophotometric ELISA microplate reader (Meter tech. S960, USA).
Prostaglandin E2 Quantitative Assay
Data Analysis
Statistical analysis, data fitting and graphics were performed by the Prism 5.03 computer program (GraphPad Software, USA). Data are given as mean ± SEM of at least three independent experiments. Multiple comparisons were carried out using one way analysis of variance (ANOVA) followed by LSD (least significant difference) post-hoc test. Statistical significance was acceptable at a level of p < 0.05. 
Results
Effect of Paracetamol Alone and in Combination with BSO on the Survival of Hepatoma Cell Line (HepG2) and Normal Rat Hepatocytes
BSO Modifies the Cell Cycle Progression of Paracetamol Treated Cells
In order to understand the mechanisms underlying the anti-proliferative effects of 
Effect of Paracetamol, BSO and Their Combination on the Expression of PGE2
Quantitative analysis of PGE2 level in normal hepatocytes showed significant increase in PGE2 level over the control after all treatment schedules except for the combination of paracetamol and BSO. That combination, on the contrary, showed a significant decrease compared with control, BSO-or paracetmol-treated cells ( Figure 5 ).
On the other hand, in HepG2 cells a totally reversed effect was noticed. A significant decrease in the level of PGE2 was observed after all treatment regimens except for both drugs combination which showed a significant increase compared with those of the control, BSO-or paracetmol-treated HepG2 cells ( Figure 5) . Changes in the level of PGE2 after different treatments for both HepG2 and normal hepatocytes are shown in Table 3 .
Discussion
Despite the great advance achieved in cancer therapy in the last decade, management of some types of malignant diseases such as liver cancer remains a great challenge. Side Figure 5 . Effect of paracetamol, BSO and their combination on prostaglandin E2 expression in HepG2 liver cancer cells and normal hepatocytes. Both Cell types either control or treated with paracetamol, BSO or their combination for 48 h were used to monitor PGE2 expression colorimetrically using PGE2 assay kit from R&D systems (USA). The assay was done according to the manufacturer's instructions. Data represent means ± SEM of at least three independent experiments each performed in triplicates. Statistical analysis was carried out using two way ANOVA followed by post-hoc test. a significantly different from the respective control group at p < 0.05. b significantly different from the respective BSO alone group at p < 0.05. effects of cancer therapeutics limit the usefulness of many anticancer agents. Therefore, there is a great interest in developing agents with different effects on malignant and normal cells or using additional components that may preferentially sensitize cancer cells to the effect of anticancer agents. Paracetamol that is approved long time ago as analgesic antipyretic is a well established hepatotoxic at high doses. This effect is attributed to its metabolite NAPQI that accumulates after depletion of glutathione stores.
The aim of the present study is to investigate the cellular effects of therapeutic-or low-dose paracetamol treatment on hepatoma cells versus normal rat hepatocytes in the presence and absence of the selective GSH-depleting agent BSO. The ultimate goal is to establish a strategy or a paracetamol-based combination therapy that may improve the outcome of liver cancer therapy with least effects on normal hepatocytes. Our results
showed that both paracetamol and BSO either alone or in combination have anti-proliferative effects on both liver cancer (HepG2) and on normal rat hepatocytes. A previous study stated that HepG2 cell line constitutively expresses CYP2E1, CYP1A2
and CYP3A4, all are involved in paracetamol metabolism [18] . This finding may explain the resulted cytotoxic effect of paracetamol on HepG2 and normal hepatocytes due to the formation of the cytotoxic metabolite NAPQI. BSO as a glutathione depleting agent induces thiol-mediated oxidative stress in cancer cells [19] . It is well established that GSH plays an important role in multidrug resistance [20] . Moreover, elevation of intracellular GSH has also been associated with mitogenic stimulation [21] .
Consequently, depletion of GSH has been found to either precede the onset of apoptosis or render the cells more sensitive to cell death [14] . These facts were confirmed by BSO either alone or in combination with low concentrations of paracetamol (1, 1.25, 1.5 mM) was also able to sensitize normal hepatocytes to paracetamol cytotoxic effects.
Surprisingly, BSO showed a reversed action when combined with higher concentrations of paracetamol (1.75 and 2 mM). At 2 mM paracetamol, BSO caused a cytoprotective effect on normal hepatocytes and cells showed enhanced survival. Cell cycle analysis of normal hepatocytes revealed that either BSO or paracetamol alone caused an increased sub G1 phase compared with control cells confirming the incidence of apotosis/necrosis or both. On the contrary, their combined effect in normal hepatocytes showed a collapsed sub G1 area, similar to the one of untreated cells, denoting lesser cytotoxicity.
This acquired cytoprotective property supported the results of SRB assay which confirmed the ability of BSO to reverse the cytotoxic action of higher doses of paracetamol in normal hepatocytes. This phenomenon might be explained by the report of Syng-ai et al. [22] who noticed that every cell line showed a different response to incubation with BSO. The current conflicting responses of both cell lines upon treatment with BSO and paracetamol combination might be attributed to their different cellular GSH content. This depends on the variability in GSH depleting ability of BSO between tumor and normal tissues [23] .
Incubation time is recognized as a reliable factor that may affect the cytotoxic effects of paracetamol, BSO, and their combination. In the present study, the best cytotoxic effects were achieved after exposure of cells to drug combinations for of 72 and 96 hours.
This may be due to the direct activation by paracetamol/BSO of endonucleases leading to induction of cell death. This finding comes in line with Manov et al. [2] who observed that paracetamol induced a significant increase in the frequency of hypodiploid nuclei in HepG2 cells in a time and concentration-dependent manner. This may be attributed to the ability of paracetamol to decrease cellular redox potential and GSH content.
Paracetamol is an inhibitor of cyclooxygenase enzymes that may affect the level of prostaglandin synthesis. Therefore, the role of prostglandins (PGs) in the cytotoxicity and their combination. While on the other hand, a totally reversed effect was shown in normal murine hepatocytes. A possible explanation for that controversy may be the diverse levels of cellular peroxides present in different types of cells [37] [38]. Paracetamol only inhibits the production of PGs from arachidonic acid under specific conditions, namely when the peroxide tone of isolated cells is low [39] .
As a fact, inhibition of COX enzyme by paracetamol and non steroidal anti inflammatory drugs (NSAIDs) is the main reason for the inhibition of PGs synthesis. Unlike aspirin, inhibition of cyclooxygenase (COX) activity by paracetamol is biphasic and requires glutathione and hydroquinone as cofactors [40] . This fact may explain why PGE2 level was increased when normal hepatocytes with low GSH level were treated with both BSO and paracetamol. As a result, the titer of PGE2 increased in normal hepatocytes when treated with paracetamol alone followed by a further increase when BSO was added to paracetamol ( Figure 5 ). This action was totally reversed in case of
HepG2 cells due to their higher levels of GSH that facilitate COX inhibition and therefore PGE2 synthesis was decreased.
Conclusion
In conclusion, paracetamol alone is more cytotoxic to the liver cancer HepG2 cells than the normal hepatocytes. Addition of BSO to paracetamol showed differential effects on cancer and normal liver cells. Enhancement of paracetamol cytotoxicity on liver cancer cells was observed at low and high paracetamol concentrations while its effect on para-cetamol toxicity on normal hepatocytes was dependent on paracetamol concentration with increased cytotoxicity at low but increased protection at high paracetamol con- 
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